To include your compound in the COVID-19 Resource Center, submit it here.

Federal judge invalidates four Restasis patents

On Monday, Allergan plc (NYSE:AGN) sank $7.11 to $198.41 after a federal judge invalidated four patents covering its dry-eye drug Restasis cyclosporine. Although the court found that

Read the full 272 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE